Company Overview

MustGrow Biologics Corp. (TSXV: MGRO) is a Canadian agricultural biotechnology company focused on developing and commercializing plant-based biological solutions for agriculture. The company operates primarily in the crop protection and soil health industries, with technologies derived from mustard seed compounds designed to provide alternatives to certain synthetic pesticides and fumigants. Its core business activities include the development of biofertility, biocontrol, and biostimulant products intended to improve crop yields, suppress soil-borne pests and diseases, and support sustainable farming practices.

The company’s primary strategic positioning is centered on natural and biological agricultural inputs that may align with increasing regulatory restrictions on conventional chemical fumigants and pesticides. MustGrow has evolved from an early-stage technology developer into a commercialization-focused agricultural platform company through licensing, field validation, and strategic collaborations. Public disclosures and investor materials indicate that the company has pursued partnerships with established agricultural industry participants to accelerate market adoption and regulatory advancement of its technologies.

Business Operations

MustGrow’s operations are focused on the commercialization and development of biological technologies derived from mustard seed extracts. Its principal operating activities include research and development, intellectual property management, field trial programs, regulatory approvals, and commercialization partnerships. The company has historically highlighted technologies associated with biofumigation, soil health enhancement, and biological crop protection products targeting high-value crops and specialty agriculture markets.

The company’s business model includes technology licensing, joint development agreements, and potential product commercialization partnerships in both domestic and international markets. MustGrow has disclosed collaborations and evaluation programs involving agricultural companies and research organizations in regions including North America and other international agricultural markets. Public filings reference proprietary intellectual property associated with mustard-derived compounds and formulations. Data regarding large-scale commercial revenue concentration remains limited based on available public disclosures.

Strategic Position & Investments

MustGrow’s strategic direction has emphasized participation in the expanding biological agriculture sector, particularly solutions positioned as sustainable alternatives to synthetic chemicals. Growth initiatives have included regulatory advancement of proprietary technologies, expansion of field trials, and strategic partnerships intended to validate efficacy across multiple crop categories. The company has also pursued opportunities in biological crop protection, organic agriculture inputs, and soil health technologies.

Public disclosures have referenced investments in product development and commercialization initiatives involving mustard-derived technologies for disease and pest suppression. MustGrow has also announced collaborations and evaluation arrangements with agricultural industry participants to support market access and product testing. The company’s strategic focus appears concentrated on emerging biological agriculture markets rather than diversified industrial operations. Data inconclusive based on available public sources regarding material wholly owned operating subsidiaries with significant independent revenue contribution.

Geographic Footprint

MustGrow Biologics Corp. is headquartered in Canada, with operations and development activities primarily associated with the North American agricultural market. The company’s research, field trials, and commercialization efforts have targeted regions with significant specialty crop and high-value agriculture production, including parts of the United States and Canada.

The company has also communicated interest in broader international agricultural opportunities through licensing discussions, partnerships, and technology evaluations. Publicly available information indicates exposure to international agricultural markets through collaborative relationships rather than large-scale owned operational infrastructure abroad. Its geographic strategy appears focused on scalable commercialization through partnerships rather than direct multinational manufacturing operations.

Leadership & Governance

MustGrow’s leadership has generally emphasized sustainable agriculture innovation, biological alternatives to synthetic crop protection products, and commercialization through strategic partnerships. Governance and management communications in public filings and investor materials have focused on advancing regulatory approvals, validating product efficacy, and building long-term intellectual property value within the biological agriculture sector.

Key executives and directors identified in public disclosures include:

• Corey Giasson – Chief Executive Officer
• Colleen McCrea – Chief Financial Officer
• Glenn Logan – Director
• Don Urban – Director

Data regarding founder attribution and historical executive continuity is inconclusive based on available public sources and may vary across reporting periods and corporate filings.